Stanford General Surgery News Center

In the News

  • – Surgery

    SHC Performs First FDA-Approved Cell Therapy for Melanoma

    Stanford Health Care (SHC) performed the first FDA-approved cell therapy for solid tumor case in the country. AMTAGVI (lifileucel) was administered to a patient with metastatic melanoma on Tuesday, February 20, 2024.

  • – Surgery

    Colorectal Cancer and Wellness with Dr. Cindy Kin

    In this episode of Scrubcast, host Rachel Baker interviews Dr. Cindy Kin, an associate professor in Stanford University's Department of Surgery. Dr. Kin delves into her choice to specialize in colorectal surgery and shares insights on the increasing trend of colon cancer in younger patients.

  • – Surgery

    Dr. Ahn Receives ATC Young Investigator Award

    Dr. Daniel Ahn is the recipient of a 2024 Young Investigator Award from the American Transplant Conference (ATC) for this abstract entitled “Adult Liver Transplant Candidates with Non-Standardized MELD Score Exceptions Have Lower Risk of Waitlist Mortality Than Standard Candidates.”

  • – Surgery

    INSIDE: PCSA24

    Stanford Surgery highlights from the 95th Annual Meeting of the Pacific Coast Surgical Association, which took place February 9-12 in Rancho Mirage, CA.

  • – Surgery

    Dr. Dirbas to Serve as Vice Chair of SSO Breast Disease Site Work Group

    Dr. Fred Dirbas has been invited to serve as the Vice Chair of the Society of Surgical Oncology (SSO) Breast Disease Site Work Group by Society President-Elect Dr. Ronald DeMatteo.